Merck & Co Azione

Merck & Co PEG

Il PEG Ratio (Rapporto prezzo-utile-crescita) di Merck & Co (MRK) al 10 ago 2026 è 2,08. L'anno precedente, PEG Ratio (Rapporto prezzo-utile-crescita) era 2,22 — una variazione del -6,23% (inferiore).

PEG

2,08

YoY

-6,23%

Ultimo aggiornamento:

PEG Ratio (Rapporto prezzo-utile-crescita) di Merck & Co ammonta a 2026 2,08 . PEG Ratio (Rapporto prezzo-utile-crescita) di Merck & Co ammontava a 2025 2,22 . Diminuisce del -6,23% inferiore rispetto all'anno precedente.
Access this data via the Eulerpool API

Merck & Co Analisi delle Azioni

Cosa fa Merck & Co? The company Merck & Co Inc has a long history. It was founded in 1891 by the German pharmacist Friedrich Jacob Merck and is now based in Kenilworth, New Jersey, USA. The company has evolved over time into a globally operating company in the pharmaceutical and chemical industry. Merck & Co Inc's business model is based on the development, production, and marketing of medicines and products for the healthcare industry. The company collaborates with other partners such as universities, other companies, and governments to achieve the best possible scientific progress. Research and development play a very important role in this. Merck is divided into three main areas: The Human Health division, which specializes in the development of prescription drugs and products to improve human health. The second division is Animal Health, which focuses on animal medicines and care products. The third division, Life Science (formerly MilliporeSigma), is dedicated to the development of products and services for biopharmaceutical research and production to facilitate the discovery and manufacturing of medicines. Merck & Co Inc. offers a wide range of products, ranging from prescription medicines to specialty chemicals. Some of the most well-known drugs include Januvia for the treatment of type 2 diabetes and Keytruda, an immuno-oncology drug used in the treatment of various types of cancer. Other well-known drugs from Merck & Co Inc. include Gardasil for the prevention of HPV infections, Propecia for the treatment of male pattern hair loss, and Zetia for the treatment of high cholesterol. The company is extremely innovative and has made significant advances in pharmaceutical research in recent decades. Merck & Co Inc. has won numerous awards over the years, including the "2018 Australian Financial Review Boss Most Innovative Companies Award" and the "2018 Global Energy Award for Technology Innovation". Merck & Co Inc. operates worldwide and has subsidiaries and partnerships in many countries. The company has about 69,000 employees and distributes its products in over 140 countries. Merck & Co Inc.'s products are typically prescription-only and prescribed by doctors and professionals. Overall, Merck & Co Inc. is a company with an impressive history that is now one of the leading companies in the pharmaceutical and chemical industry. Thanks to its innovation and its consistent focus on the needs of patients and healthcare professionals, it is able to successfully meet challenges in the healthcare industry and set new standards. Merck & Co è una delle aziende più popolari su Eulerpool.com.

Domande frequenti su Merck & Co azioni

PEG Ratio (Rapporto prezzo-utile-crescita) di Merck & Co è 2,08 nel 2026.

Il PEG Ratio (Rapporto prezzo-utile-crescita) di Merck & Co è passato da 2,22 a 2,08, con una variazione del -6,23 %. Il valore è inferiore rispetto all'anno precedente.

Su Eulerpool è possibile consultare lo sviluppo storico completo del Merck & Co di PEG Ratio (Rapporto prezzo-utile-crescita) dal 2006, con valori annuali, grafici e analisi dettagliate.

Il rapporto PEG rettifica il P/E in base al tasso di crescita atteso dei guadagni. Un PEG inferiore a 1 può indicare un'azione sottovalutata rispetto al suo potenziale di crescita.

PEG = Rapporto P/E / Tasso di crescita annuale atteso dell'EPS

Per valutare di PEG Ratio (Rapporto prezzo-utile-crescita), è essenziale confrontarlo con i competitor nello stesso settore e industria. Su Eulerpool puoi trovare confronti diretti con l'industria per PEG Ratio (Rapporto prezzo-utile-crescita).

Un 'buono' varia a seconda del settore e della fase di sviluppo dell'azienda. Su Eulerpool puoi confrontare Merck & Co di PEG Ratio (Rapporto prezzo-utile-crescita) con i competitor del settore e la media industriale per valutare se è attraente.

Access this data via the Eulerpool API

Valutazione — Merck & Co

Tutte le Metriche Finanziarie — Merck & Co